September 29, 2020

DO NOT DOCKET. CASE HAS BEEN TRANSFERRED OUT.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 07, 2021

    Insurers Urge Court To Preserve Cancer Drug Antitrust Suit

    Four insurance companies fought back Wednesday against a Bristol-Myers Squibb unit's efforts to stamp out their antitrust lawsuit, claiming they suffered injuries after Celgene sold cancer medicines Thalomid and Revlimid at supracompetitive prices.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login